Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion in Patients with Prior Treatment with Bevacizumab or Ranibizumab

被引:0
|
作者
van Zyl, Tave [1 ]
Papakostas, Thanos D. [1 ]
Lim, Laurence Shen [1 ,2 ]
Miller, John B. [1 ]
Husain, Deeba [1 ]
Eliott, Dean [1 ]
Kim, Leo A. [1 ]
机构
[1] Massachusetts Eye & Ear Infirm, Ophthalmol, Boston, MA 02114 USA
[2] Singapore Natl Eye Ctr, Ophthalmol, Singapore, Singapore
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
4623
引用
下载
收藏
页数:2
相关论文
共 50 条
  • [31] Morphological and electrophysiological outcome in prospective intravitreal bevacizumab treatment of macular edema secondary to central retinal vein occlusion
    Topcic, Ivana Gardasevic
    Sustar, Maja
    Brecelj, Jelka
    Hawlina, Marko
    Mekjavic, Polona Jaki
    DOCUMENTA OPHTHALMOLOGICA, 2014, 129 (01) : 27 - 38
  • [32] Morphological and electrophysiological outcome in prospective intravitreal bevacizumab treatment of macular edema secondary to central retinal vein occlusion
    Ivana Gardašević Topčić
    Maja Šuštar
    Jelka Brecelj
    Marko Hawlina
    Polona Jaki Mekjavić
    Documenta Ophthalmologica, 2014, 129 : 27 - 38
  • [33] Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusion
    Demir, Mehmet
    Dirim, Burcu
    Acar, Zeynep
    Sendul, Yekta
    Oba, Ersin
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2014, 62 (03) : 279 - 283
  • [34] Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
    Otawa, Taro
    Noma, Hidetaka
    Yasuda, Kanako
    Narimatsu, Akitomo
    Asakage, Masaki
    Tanaka, Akina
    Goto, Hiroshi
    Shimura, Masahiko
    BMC OPHTHALMOLOGY, 2022, 22 (01)
  • [35] Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
    Taro Otawa
    Hidetaka Noma
    Kanako Yasuda
    Akitomo Narimatsu
    Masaki Asakage
    Akina Tanaka
    Hiroshi Goto
    Masahiko Shimura
    BMC Ophthalmology, 22
  • [36] Bevacizumab for treatment of macular edema secondary to retinal vein occlusion
    Jaissle, G. B.
    Ziemssen, F.
    Petermeier, K.
    Szurman, P.
    Ladewig, M.
    Gelisken, F.
    Voelker, M.
    Holz, F. G.
    Bartz-Schmidt, K. U.
    OPHTHALMOLOGE, 2006, 103 (06): : 471 - 475
  • [37] Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
    Schaal, K. B.
    Hoeh, A. E.
    Scheuerle, A.
    Schuett, F.
    Dithmar, S.
    OPHTHALMOLOGE, 2007, 104 (04): : 285 - 289
  • [38] Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion
    Yoshitsugu Saishin
    Yuka Ito
    Masato Fujikawa
    Tomoko Sawada
    Masahito Ohji
    Japanese Journal of Ophthalmology, 2017, 61 : 67 - 73
  • [39] The Efficacy of Intravitreal Ranibizumab and Dexamethasone Implant in Macular Edema Secondary to Branch and Central Retinal Vein Occlusion
    Yucel, Ozlem Eski
    Niyaz, Leyla
    Sullu, Yuksel
    Birinci, Hakki
    OPHTHALMOLOGICA, 2014, 232 : 94 - 94
  • [40] RETINAL SENSITIVITY AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION
    Yamaike, Noritatsu
    Tsujikawa, Akitaka
    Sakamoto, Atsushi
    Ota, Masafumi
    Kotera, Yuriko
    Miyamoto, Kazuaki
    Kita, Mihori
    Yoshimura, Nagahisa
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (06): : 757 - 767